v3.25.4
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
 12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
The following presents the detailed calculation of EPS:
 Year Ended December 31,
(MILLIONS)
202520242023
EPS Numerator  
Income from continuing operations attributable to Pfizer Inc. common shareholders$7,745 $8,020 $2,134 
Discontinued operations––net of tax25 11 (15)
Net income attributable to Pfizer Inc. common shareholders$7,771 $8,031 $2,119 
EPS Denominator  
Weighted-average common shares outstanding––Basic
5,683 5,664 5,643 
Common-share equivalents31 36 66 
Weighted-average common shares outstanding––Diluted
5,713 5,700 5,709 
Anti-dilutive common stock equivalents(a)
11 24 9 
(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.